Integer Holdings Corporation (ITGR)

NYSE Health Care Health Care Equipment S&P SmallCap 600
$126.56
-0.19 (-0.15%)
Close of Nov 06, 2026 · end-of-day data
Source: Integer Holdings Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$1.08B$1.14B$1.22B$1.26B$1.07B$1.22B$1.33B$1.56B$1.72B$1.85B
Cost of revenue$737.82M$782.07M$852.35M$903.08M$787.74M$884.11M$985.52M$1.15B$1.26B$1.35B
Gross profit$337.68M$354.01M$362.67M$355.01M$285.71M$336.97M$345.76M$409.89M$459.01M$500.39M
Research & development$47.90M$48.85M$48.60M$46.53M$48.47M$51.98M$59.76M$61.97M$53.42M$49.50M
Selling, general & admin$136.44M$143.07M$142.44M$138.69M$109.01M$141.42M$158.05M$173.17M$185.20M$211.75M
Operating income$92.92M$125.65M$155.56M$157.63M$120.61M$135.71M$112.68M$163.32M$208.24M$221.26M
Interest expense$68.33M$63.97M$99.31M$52.55M$38.22M$31.63M$38.63M$53.37M$56.37M$43.21M
Pre-tax income$28.16M$49.26M$61.12M$105.19M$86.21M$101.06M$68.68M$105.38M$147.56M$125.40M
Income tax$3.29M-$37.83M$14.08M$13.97M$8.95M$8.04M$8.93M$16.24M$26.51M$22.57M
Net income$5.96M$66.68M$167.96M$96.34M$77.26M$96.81M$66.38M$90.65M$119.90M$102.81M
EBITDA$183.45M$228.44M$244.54M$235.53M$199.94M$217.08M$204.67M$262.16M$319.27M$351.93M
EPS (basic)$0.19$2.12$5.23$2.95$2.35$2.93$2.00$2.72$3.57$2.96
EPS (diluted)$0.19$2.08$5.15$2.92$2.33$2.91$1.99$2.69$3.36$2.89
Diluted shares30.97M32.06M32.60M33.04M33.11M33.26M33.36M33.76M35.65M35.59M
Gross margin31.4%31.2%29.8%28.2%26.6%27.6%26.0%26.3%26.7%27.0%
Operating margin8.6%11.1%12.8%12.5%11.2%11.1%8.5%10.5%12.1%11.9%
Net margin0.6%5.9%13.8%7.7%7.2%7.9%5.0%5.8%7.0%5.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$52.12M$44.10M$25.57M$13.54M$49.21M$17.89M$24.27M$23.67M$46.54M$17.16M
Receivables$204.63M$194.84M$185.50M$191.99M$156.21M$182.31M$224.32M$231.28M$245.27M$346.08M
Inventory$225.15M$176.74M$190.08M$167.26M$149.32M$155.70M$208.77M$229.10M$247.13M$253.74M
Total current assets$517.31M$531.91M$416.25M$415.39M$412.94M$452.98M$558.30M$617.67M$671.12M$770.10M
Goodwill$967.33M$839.87M$832.34M$839.62M$859.44M$924.70M$965.19M$994.01M$1.02B$1.11B
Total assets$2.83B$2.85B$2.33B$2.35B$2.37B$2.58B$2.79B$2.94B$3.08B$3.41B
Total current liabilities$185.22M$209.00M$164.57M$179.08M$156.19M$159.63M$223.75M$220.97M$227.17M$232.04M
Short-term debt$31.34M$30.47M$37.50M$37.50M$37.50M$15.25M$18.19M$0$10.00M$0
Long-term debt$1.70B$1.58B$888.01M$777.27M$693.76M$812.88M$907.07M$959.92M$980.15M$1.19B
Total debt$1.73B$1.61B$925.51M$814.77M$731.26M$828.13M$925.26M$959.92M$990.15M$1.19B
Total liabilities$2.11B$1.95B$1.27B$1.20B$1.10B$1.23B$1.38B$1.42B$1.46B$1.66B
Shareholders' equity$725.24M$893.38M$1.06B$1.15B$1.27B$1.35B$1.42B$1.52B$1.62B$1.75B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$105.53M$149.36M$167.30M$165.36M$181.34M$156.67M$116.38M$180.21M$205.21M$196.15M
Capital expenditures$58.63M$47.30M$44.91M$48.20M$46.83M$53.46M$74.73M$119.94M$105.36M$91.03M
Free cash flow$46.90M$102.06M$122.39M$117.16M$134.51M$103.20M$41.65M$60.27M$99.85M$105.12M
Investing cash flow-$63.30M-$47.94M$536.67M-$58.86M-$56.58M-$271.00M-$200.42M-$163.37M-$195.41M-$270.73M
Financing cash flow-$72.15M-$111.67M-$725.08M-$117.93M-$88.58M$81.99M$92.48M-$18.01M$13.32M$43.56M
Share buybacks———————$0$0$50.01M
Stock-based compensation$8.41M$14.68M$10.47M$9.29M$9.16M$16.18M$21.02M$23.28M$24.77M$23.22M
Depreciation & amortization$90.52M$102.80M$88.99M$77.89M$79.32M$81.37M$91.99M$98.84M$111.03M$130.67M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.